Publication | Closed Access

Tumor-infiltrating lymphocytes are significantly associated with better overall survival and disease-free survival in triple-negative but not estrogen receptor–positive breast cancers

Better Overall SurvivalBreast OncologyCancer ImmunosurveillanceMedicineImmunologyTumor ImmunityPathologyBreast CancerDisease-free SurvivalOncologyTumor MicroenvironmentEndocrine-related CancerTumor-infiltrating Lymphocytes